-
BCRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
BioCryst Pharmaceuticals (BCRX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 99.06 mm | 99.06 mm | 99.06 mm | 99.06 mm | 99.06 mm | 99.06 mm |
Cash burn (monthly) | (no burn) | 4.32 mm | 4.48 mm | 10.34 mm | (no burn) | 4.64 mm |
Cash used (since last report) | n/a | 17.38 mm | 18.03 mm | 41.60 mm | n/a | 18.68 mm |
Cash remaining | n/a | 81.69 mm | 81.04 mm | 57.46 mm | n/a | 80.39 mm |
Runway (months of cash) | n/a | 18.9 | 18.1 | 5.6 | n/a | 17.3 |
13F holders | Current |
---|---|
Total holders | 256 |
Opened positions | 53 |
Closed positions | 35 |
Increased positions | 79 |
Reduced positions | 73 |
13F shares | Current |
---|---|
Total value | 1.25 tn |
Total shares | 172.64 mm |
Total puts | 738.90 k |
Total calls | 624.80 k |
Total put/call ratio | 1.2 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 20.92 mm | $158.96 bn |
Vanguard | 20.31 mm | $154.33 bn |
Avoro Capital Advisors | 11.87 mm | $90.17 bn |
Kynam Capital Management | 9.09 mm | $69.05 bn |
STT State Street | 8.85 mm | $67.26 bn |
Deerfield Management | 8.14 mm | $61.83 bn |
Alkeon Capital Management | 7.09 mm | $53.91 bn |
Geode Capital Management | 4.84 mm | $36.78 bn |
Nuveen Asset Management | 4.81 mm | $36.59 bn |
RP Management | 3.85 mm | $29.23 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Dec 24 | Stonehouse Jon P | Common Stock | Gift | Acquire G | Yes | No | 0 | 10,000 | 0.00 | 30,000 |
20 Dec 24 | Stonehouse Jon P | Common Stock | Gift | Acquire G | Yes | No | 0 | 10,000 | 0.00 | 30,000 |
20 Dec 24 | Stonehouse Jon P | Common Stock | Gift | Dispose G | No | No | 0 | 20,000 | 0.00 | 1,429,109 |
19 Dec 24 | Stonehouse Jon P | Common Stock | Payment of exercise | Dispose F | No | No | 7.39 | 14,010 | 103.53 k | 1,449,109 |
19 Dec 24 | Stonehouse Jon P | Common Stock | Grant | Acquire A | No | No | 0 | 362,100 | 0.00 | 1,463,119 |
19 Dec 24 | Stonehouse Jon P | Emp. Stock Option Common Stock | Grant | Acquire A | No | No | 7.39 | 750,250 | 5.54 mm | 750,250 |
19 Dec 24 | Anthony Doyle | Common Stock | Payment of exercise | Dispose F | No | No | 7.39 | 2,461 | 18.19 k | 377,867 |
19 Dec 24 | Anthony Doyle | Common Stock | Grant | Acquire A | No | No | 0 | 120,700 | 0.00 | 380,328 |
19 Dec 24 | Anthony Doyle | Emp. Stock Option Common Stock | Grant | Acquire A | No | No | 7.39 | 250,100 | 1.85 mm | 250,100 |
19 Dec 24 | Alane P Barnes | Common Stock | Payment of exercise | Dispose F | No | No | 7.39 | 2,461 | 18.19 k | 412,729 |